[Anti-tumor immune response against mouse melanoma to xenogeneic vaccination]
- PMID: 11783014
[Anti-tumor immune response against mouse melanoma to xenogeneic vaccination]
Abstract
Objective: To study the inhibition of melanoma growth in mice by vaccination with xenogeneic melanocytes.
Methods: Xenogeneic vaccine was prepared from pig eye melanocytes. It was used before or after B16 melanoma challenge in C57 mice. The size of tumor was monitored. Cytotoxic T lymphocyte (CTL) activity of mouse spleen cells was measured by 51Cr release assay. Antibody response against pig melanocytes and B16 melanoma cells were detected by indirect ELISA.
Results: Preventive vaccination resulted in inhibition of tumor growth in 90% of the immunized mice, while therapeutic vaccination inhibited tumor growth in 50% of the treated mice. Specific CTL activity and antibodies in the immunized mice were detected.
Conclusion: Anti-tumor immune response capable of inhibiting melanoma growth can be induced by xenogeneic melanocyte vaccination.
Similar articles
-
[The mechanism of anti-tumor immune response against mouse melanoma to xenogeneic vaccination].Sichuan Da Xue Xue Bao Yi Xue Ban. 2004 Nov;35(6):757-60. Sichuan Da Xue Xue Bao Yi Xue Ban. 2004. PMID: 15573746 Chinese.
-
Vaccination with B16 melanoma cells expressing a secreted form of interleukin-1beta induces tumor growth inhibition and an enhanced immunity against the wild-type B16 tumor.Cancer Gene Ther. 2000 Oct;7(10):1365-74. doi: 10.1038/sj.cgt.7700248. Cancer Gene Ther. 2000. PMID: 11059695
-
[Anti-metastatic effect of vascular endothelial growth factor receptor 2 extracellular domain gene-modified dendritic cell vaccination in murine model with experimental pulmonary metastasis].Zhonghua Zhong Liu Za Zhi. 2006 Sep;28(9):646-9. Zhonghua Zhong Liu Za Zhi. 2006. PMID: 17274366 Chinese.
-
Tumor vaccination for malignant brain tumors.Pediatr Blood Cancer. 2010 Apr;54(4):495-6. doi: 10.1002/pbc.22388. Pediatr Blood Cancer. 2010. PMID: 19998471 Review. No abstract available.
-
Explanations for reduced tumor proliferative capacity with age.Exp Gerontol. 1992 Sep-Dec;27(5-6):551-8. doi: 10.1016/0531-5565(92)90009-o. Exp Gerontol. 1992. PMID: 1426087 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical